CIK 1389426
Rafferty Asset Management, LLC
Institutional 13F holdings & portfolio
Holdings
1,133
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 1051–1100 of 1,133
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| RPRX | ROYALTY PHARMA PLC | 6K | $100K–$500K | SH |
| TARS | TARSUS PHARMACEUTICALS INC | 3K | $100K–$500K | SH |
| PBH | PRESTIGE CONSMR HEALTHCARE I | 4K | $100K–$500K | SH |
| AVDL | AVADEL PHARMACEUTICALS PLC | 11K | $100K–$500K | SH |
| AMBA | AMBARELLA INC | 3K | $100K–$500K | SH |
| FNF | FIDELITY NATIONAL FINANCIAL | 4K | $100K–$500K | SH |
| OGN | ORGANON & CO | 33K | $100K–$500K | SH |
| AA | ALCOA CORP | 4K | $100K–$500K | SH |
| NCNO | NCINO INC | 9K | $100K–$500K | SH |
| PHAT | PHATHOM PHARMACEUTICALS INC | 14K | $100K–$500K | SH |
| EQH | EQUITABLE HLDGS INC | 5K | $100K–$500K | SH |
| GGG | GRACO INC | 3K | $100K–$500K | SH |
| HROW | HARROW INC | 5K | $100K–$500K | SH |
| INVA | INNOVIVA INC | 11K | $100K–$500K | SH |
| CRNX | CRINETICS PHARMACEUTICALS IN | 5K | $100K–$500K | SH |
| HUT | HUT 8 CORP | 5K | $100K–$500K | SH |
| ESPR | ESPERION THERAPEUTICS INC NE | 61K | $100K–$500K | SH |
| ANIP | ANI PHARMACEUTICALS INC | 3K | $100K–$500K | SH |
| RGA | REINSURANCE GRP OF AMERICA I | 1K | $100K–$500K | SH |
| CSL | CARLISLE COS INC | 701 | $100K–$500K | SH |
| RPM | RPM INTL INC | 2K | $100K–$500K | SH |
| MTZ | MASTEC INC | 1K | $100K–$500K | SH |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 6K | $100K–$500K | SH |
| LECO | LINCOLN ELEC HLDGS INC | 925 | $100K–$500K | SH |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 5K | $100K–$500K | SH |
| EVR | EVERCORE INC | 650 | $100K–$500K | SH |
| OHI | OMEGA HEALTHCARE INVS INC | 5K | $100K–$500K | SH |
| DT | DYNATRACE INC | 5K | $100K–$500K | SH |
| WULF | TERAWULF INC | 19K | $100K–$500K | SH |
| APLD | APPLIED DIGITAL CORP | 9K | $100K–$500K | SH |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 65K | $100K–$500K | SH |
| RNR | RENAISSANCERE HLDGS LTD | 775 | $100K–$500K | SH |
| MAZE | MAZE THERAPEUTICS INC | 5K | $100K–$500K | SH |
| NXT | NEXTPOWER INC | 2K | $100K–$500K | SH |
| HL | HECLA MNG CO | 11K | $100K–$500K | SH |
| EVGO | EVGO INC | 74K | $100K–$500K | SH |
| SF | STIFEL FINL CORP | 2K | $100K–$500K | SH |
| MLI | MUELLER INDS INC | 2K | $100K–$500K | SH |
| AMLX | AMYLYX PHARMACEUTICALS INC | 18K | $100K–$500K | SH |
| ALLY | ALLY FINL INC | 5K | $100K–$500K | SH |
| GLPI | GAMING & LEISURE PPTYS INC | 5K | $100K–$500K | SH |
| ACM | AECOM | 2K | $100K–$500K | SH |
| TERN | TERNS PHARMACEUTICALS INC | 5K | $100K–$500K | SH |
| MEDP | MEDPACE HLDGS INC | 374 | $100K–$500K | SH |
| OMER | OMEROS CORP | 12K | $100K–$500K | SH |
| ARVN | ARVINAS INC | 18K | $100K–$500K | SH |
| CAL | CALERES INC | 17K | $100K–$500K | SH |
| CORZ | CORE SCIENTIFIC INC NEW | 14K | $100K–$500K | SH |
| CRMD | CORMEDIX INC | 18K | $100K–$500K | SH |
| TRVI | TREVI THERAPEUTICS INC | 16K | $100K–$500K | SH |